ARK Invest deployed $25.13 million into Rocket Lab as shares sit 53% below peak

Verifying
  • ARK Invest bought 359,612 Rocket Lab shares through three funds.
  • Rocket Lab shares settled at $70.31, approximately 53% below their $151 52-week peak.
  • ARK also accumulated Scribe Therapeutics while reducing Alphabet, AMD and Palantir holdings.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.